Log in to save to my catalogue

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3504218

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

About this item

Full title

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

Publisher

Cairo, Egypt: Hindawi Limiteds

Journal title

Leukemia Research and Treatment, 2012-01, Vol.2012 (2012), p.215-222

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Limiteds

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Adult T-cell leukaemia/lymphoma (ATLL) is an aggressive malignancy of mature activated T cells caused by human T-cell lymphotropic virus type I (HTLV-1). Prognosis is severe because of intrinsic chemoresistance and severe immuosuppression. Four different subtypes are described with different outcomes, and treatment strategies vary according to the...

Alternative Titles

Full title

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3504218

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3504218

Other Identifiers

ISSN

2090-3219

E-ISSN

2090-3227

DOI

10.1155/2012/932175

How to access this item